LitAlert ~~ GeneLit.com

    • Surgical and Oncologic Outcomes of Robotic and Conventional Nipple-Sparing Mastectomy with Immediate Reconstruction: International Multicenter Pooled Data Analysis.
    • Park HS, Lee J, Lai HW, Park JM, Ryu JM, Lee JE, Kim JY, Marrazzo E, De Scalzi AM, Corso G, Montemurro F, Gazzetta G, Pozzi G, Toesca A.
    • Ann Surg Oncol. 2022 May 18. doi: 10.1245/s10434-022-11865-x. Epub ahead of print.
    • Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors.
    • Mekonnen N, Yang H, Shin YK.
    • Front Oncol. 2022 May 18;12:880643. doi: 10.3389/fonc.2022.880643.
    • State of the science: Contemporary front-line treatment of advanced ovarian cancer.
    • Hinchcliff E, Westin SN, Herzog TJ.
    • Gynecol Oncol. 2022 May 17:S0090-8258(22)00275-X. doi: 10.1016/j.ygyno.2022.04.021. Epub ahead of print.
    • Review
    • Ovarian cancer recurrence: is the definition of platinum sensitivity modified by PARPi, bevacizumab or other intervening treatments? : a clinical perspective.
    • Rose PG.
    • Cancer Drug Resist. 2022 May 12;5:415-423. doi: 10.20517/cdr.2022.01.
    • Ovarian cancer recurrence: is the definition of platinum resistance modified by PARPi and other intervening treatments? The evolving landscape in the management of platinum-resistant ovarian cancer.
    • Flynn MJ, Ledermann JA.
    • Cancer Drug Resist. 2022 May 12;5:424-435. doi: 10.20517/cdr.2022.13.